Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors (Q35027347)

5 August 2017

Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors (English)

1 reference

5 August 2017

1 reference

Tirassa P

1

1 reference

5 August 2017

Stenfors C

series ordinal

2

1 reference

5 August 2017

Lundeberg T

series ordinal

3

1 reference

5 August 2017

Aloe L

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

British Journal of Pharmacology

5 August 2017

1 reference

5 August 2017

123

1 reference

5 August 2017

6

1 reference

5 August 2017

1230-1236

1 reference

Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus

5 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

Should intracerebroventricular nerve growth factor be used to treat Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

Adrenalectomy decreases nerve growth factor in young adult rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Regulation of Neurotrophin mRNA Expression in the Rat Brain by Glucocorticoids.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Cholecystokinin stimulates and inhibits lordosis behavior in female rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Characterization of type A and type B CCK receptor binding sites in rat vagus nerve

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Immunochemical evidence of cholecystokinin-like peptides in brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Neurotrophins and their receptors--current concepts and implications for neurologic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

From mechanisms to drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Examination of the effects of cholecystokinin 26-33 and neuropeptide Y on responses of visual cortical neurons of the cat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

The nerve growth factor 35 years later

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Differential Regulation of Nerve Growth Factor (NGF) Synthesis in Neurons and Astrocytes by Glucocorticoid Hormones.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Capsaicin pretreatment attenuates multiple responses to cholecystokinin in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Blood-brain barrier permeability to peptides: Pitfalls in measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Changes in brain neuropeptide Y induced by cholecystokinin peptides.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Age-dependent effects of CCK and devazepide in male and female rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Do glucocorticoid concentrations rise with age in the rat?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Nerve growth factor and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Amelioration of delayed neuronal death in the hippocampus by nerve growth factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

The physiological function of nerve growth factor in the central nervous system: comparison with the periphery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

CCK antagonists: pharmacology and therapeutic interest.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Effect of nerve growth factor on the lesioned septohippocampal cholinergic system of aged rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701718

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701718

1 reference

release_ji7ofrxy3nfcrfgghqtotb3tt4

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ji7ofrxy3nfcrfgghqtotb3tt4

24 November 2022

mapped directly with Wikidata item

PMCID

1565271

1 reference

5 August 2017

1 reference